Table 3.
Detailed Review of Patients Treated with EVAC
| Patient No. | Sex/age, yr | SEMS before EVAC | Operation | TNM stage/ pathology | Size of leak, cm | Success to closure | Duration of SEMS, day | Duration of EVAC, day | EVAC change | Follow-up, day | Stricture within 1 yr |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | M/68 | Yes | PG with DTR | T1bN0 AWD |
2.0 | Yes | 46 | 16 | Yes | 362 | No |
| 2 | M/56 | Yes | TG with RY | T1bN0 AMD |
2.1 | Yes | 6 | 15 | No | 361 | No |
| 3 | M/74 | Yes | PG with DTR | T1bN0 AMD |
2.5 | Yes | 12 | 21 | Yes | 523 | No |
| 4 | M/55 | Yes | PG with DTR | T1aN0 AMD |
3.0 | Yes | 21 | 6 | No | 748 | No |
| 5 | M/58 | Yes | PG with DTR | T1bN0 APD |
3.3 | Yes | 38 | 15 | Yes | 718 | Yes |
| 6 | M/80 | Yes | TG with RY | T4N3 APD |
2.0 | Yes | 16 | 23 | Yes | 530 | No |
| 7 | M/81 | Yes | STG-BI | T1bN1 APD |
3.0 | Yes | 12 | 13 | No | 246 | No |
| 8 | F/65 | No | STG-BI | T1aN0 SRC |
2.0 | Yes | NA | 6 | No | 27 | No |
| 9 | M/63 | No | STG-BI | T1bN0 AMD |
2.5 | Yes | NA | 13 | No | 367 | No |
| 10 | F/68 | No | STG-BII | T4N3 APD |
2.0 | Yes | NA | 17 | Yes | 30 | No |
| 11 | M/70 | No | STG-BI | G3N0 NET |
1.5 | Yes | NA | 6 | No | 55 | No |
EVAC, endoscopic vacuum-assisted closure; SEMS, self-expandable metallic stent; M, male; F, female; PG, proximal gastrectomy; DTR, double tract reconstruction; TG, total gastrectomy; RY, Roux-en Y esophagojejunostomy; STG-BI, subtotal gastrectomy with gastroduodenostomy; STG-BII, subtotal gastrectomy with gastrojejunostomy; AWD, adenocarcinoma, well-differentiated; AMD, adenocarcinoma, moderately differentiated; APD, adenocarcinoma, poorly differentiated; SRC, signet ring cell carcinoma; NET, neuroendocrine tumor; NA, not available.